VanEckHealthBBH · Nasdaq
VanEck Biotech ETF (BBH)
- Price
- $229.39
- —11 Sept 2026
- Assets
- $469.4M
- Total net assets
- Expense ratio
- 0.35%
- Category 1.00%
- Yield
- 0.40%
- Trailing distributions
- 3Y CAGR
- 13.0%-0.5%
- Category 13.5%
- 5Y CAGR
- 1.6%-0.3%
- Category 1.9%
Loading NAV history…
VanEck Biotech ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
Holdings
The 10 largest positions make up 72.6% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| AMGN | Amgen Inc | 15.66% |
| GILD | Gilead Sciences Inc | 12.68% |
| VRTX | Vertex Pharmaceuticals Inc | 8.54% |
| REGN | Regeneron Pharmaceuticals Inc | 6.80% |
| MRNA | Moderna Inc | 5.70% |
| NTRA | Natera Inc | 5.08% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 5.03% |
| IQV | IQVIA Holdings Inc | 5.02% |
| ARGX | argenx SE ADR | 4.72% |
| ILMN | Illumina Inc | 3.34% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 25.3
- P/B
- 5.1
- P/S
- 5.5
- P/CF
- 19.2
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks100.0%
- Cash0.0%
ETF details
- Issuer
- VanEck
- Category
- Equity · Health
- Ticker
- BBH
- Exchange
- Nasdaq
- Inception
- 20 Dec 2011 (14.7 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.35% (category 1.00%)
- Holdings turnover
- 19% (category 51%)
- Distribution yield
- 0.40%
- Beta, 3 years
- 0.62
- Total net assets
- $469.4M
Prices and returns as of 11 Sept 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- PINK · Simplify Health Care ETFSimplify Asset Management · $373.7M · ER 0.51%
- PTH · Invesco Dorsey Wright Healthcare Momentum ETFInvesco · $269.8M · ER 0.60%5Y 1.7%
- IDNA · iShares Genomics Immunology and Healthcare ETFiShares · $256.7M · ER 0.47%5Y -6.1%
- SBIO · ALPS Medical Breakthroughs ETFALPS · $240M · ER 0.50%5Y 7.3%
- XHS · State Street SPDR S&P Health Care Services ETFState Street Investment Management · $212.7M · ER 0.35%5Y 4.7%
- CANC · Tema Oncology ETFTema ETFs · $211.1M · ER 0.75%